A0001 Starts Clinical Development
Transcript
This is a really exciting time for Edison Pharmaceuticals in that our first molecule is heading into the clinic. Our first compound, A0001 is heading into clinical development in Q2, 2008, and behind that are several more compounds that we expect to be nominating a lead and ultimately a clinical candidate from by the end of Q4, 2008.